The MiniMed 780G is the next iteration of the 670G hybrid closed loop system. Improvements and new features include automatic correction boluses, Bluetooth connectivity, remote software updating, a time-in-range goal greater than 80%, and an adjustable target blood glucose level down to 100 mg/dl. It will be enrolling up to 350 people with type 1 diabetes ages seven and up.
Medtronic’s next-gen CGM will only require calibration on day one of the seven-day sensor. It will be enrolling up to 460 people with both type 1 and type 2 diabetes ages two and up. Read more here.
https://clinicaltrials.gov/ct2/show/NCT03966911
From www.diabtribe.org
Nyhetsinfo
www r ed DiabetologNytt